alaproclate has been researched along with physostigmine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bidziński, A; Hauptmann, M; Kostowski, W; Płaźnik, A; Tamborska, E | 1 |
| Bartfai, T; Danielsson, E; Nordström, O; Ogren, SO; Peterson, LL | 1 |
| Davis, KL; Hollander, E; Mohs, RC | 1 |
| Bartfai, T; Carlsson, S; Ogren, SO | 1 |
2 review(s) available for alaproclate and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
1 trial(s) available for alaproclate and physostigmine
| Article | Year |
|---|---|
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
3 other study(ies) available for alaproclate and physostigmine
| Article | Year |
|---|---|
Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.
Topics: Alanine; Amphetamine; Animals; Antidepressive Agents; Atropine; Brain; Desipramine; Diazepam; Electroshock; Escape Reaction; Male; Motor Activity; Neurotransmitter Agents; Physostigmine; Rats; Rats, Inbred Strains; Valproic Acid | 1988 |
In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker.
Topics: Alanine; Animals; Brain; Cyclic GMP; Drug Synergism; Hippocampus; Male; Mice; Oxotremorine; Physostigmine; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Receptors, Serotonin; Tremor | 1985 |
Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
Topics: Alanine; Animals; Arecoline; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Oxotremorine; Parasympathomimetics; Physostigmine; Rats; Rats, Inbred Strains; Salivation; Serotonin; Serotonin Antagonists; Tremor | 1985 |